Daxor Corp (DXR) - Product Pipeline Analysis, 2023 Update

Summary


Daxor Corp (Daxor) is a biotechnology company, which offers original medical equipment for medical personnel. The company manufactures blood volume analyzers. Its flagship product, BVA-100 blood volume analyzer is an instrument to measure human blood volume. The product is used in conjunction with Volumex, a diagnostic radiopharmaceutical containing iodinated I 131 albumins. It finds application in a range of medical and surgical conditions which includes congestive heart failure, intensive care unit medicine, critical care medicine, syncope, kidney failure, hypertension, renal failure, red blood cell abnormalities, hyponatremia and other conditions. The company offers its product to hospitals, clinics, and physicians. Daxor is headquartered in Oak Ridge, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Daxor Corp
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company


Daxor Corp Company Overview
Daxor Corp Company Snapshot
Daxor Corp Pipeline Products and Ongoing Clinical Trials Overview
Daxor Corp – Pipeline Analysis Overview
Business Description
Daxor Corp - Key Facts
Daxor Corp - Major Products and Services
Daxor Corp Pipeline Products by Development Stage
Daxor Corp Ongoing Clinical Trials by Trial Status
Daxor Corp Pipeline Products Overview
BVA-100 - Acute Decompensated Heart Failure
BVA-100 - Acute Decompensated Heart Failure Product Overview
BVA-100 - Acute Decompensated Heart Failure Clinical Trial
BVA-100 - POTS
BVA-100 - POTS Product Overview
BVA-100 Combat Casualty Care
BVA-100 Combat Casualty Care Product Overview
BVA-100 Glomerular Filtration Rate
BVA-100 Glomerular Filtration Rate Product Overview
Clinical Decision Support Software
Clinical Decision Support Software Product Overview
Max-200
Max-200 Product Overview
Next Gen BVA-100
Next Gen BVA-100 Product Overview
Point-Of-Care Diagnostic Device - Heart Failure
Point-Of-Care Diagnostic Device - Heart Failure Product Overview
Total Body Albumin Algorithm
Total Body Albumin Algorithm Product Overview
Daxor Corp - Key Competitors
Daxor Corp - Key Employees
Daxor Corp - Key Employee Biographies
Daxor Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Daxor Corp, Recent Developments
Mar 02, 2023: Daxor to Report Fiscal Year 2022 Financial Results on Wednesday, March 1, 2023 and Provide Corporate Update
Jan 13, 2023: Daxor Corporation to exhibit at the Society for Critical Care Medicine 2023 Critical Care Congress
Sep 26, 2022: Daxor Corporation to Exhibit at the Annual Scientific Meeting of the Heart Failure Society of America
Sep 06, 2022: Daxor Corporation to Attend the H.C. Wainwright 24th Annual Global Investment Conference
Aug 24, 2022: Daxor to Report First Half 2022 Financial Results on Thursday, August 25, 2022, and Provide Corporate Update
May 12, 2022: Daxor to Present at the H.C. Wainwright & Company Global Investment Conference
Mar 23, 2022: Daxor Corp to Participate in the Maxim Group 2022 Virtual Growth Conference
Jan 21, 2022: Caleb DesRosiers, JD, MPA Appointed to Daxor Board of Directors
Jan 06, 2022: Daxor to present at the H.C. Wainwright BioConnect 2022 Virtual Conference
Sep 07, 2021: Daxor to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Table 1: Daxor Corp Pipeline Products and Ongoing Clinical Trials Overview
Table 2: Daxor Corp Pipeline Products by Equipment Type
Table 3: Daxor Corp Pipeline Products by Indication
Table 4: Daxor Corp, Key Facts
Table 5: Daxor Corp, Major Products and Services
Table 6: Daxor Corp Number of Pipeline Products by Development Stage
Table 7: Daxor Corp Pipeline Products Summary by Development Stage
Table 8: Daxor Corp Ongoing Clinical Trials by Trial Status
Table 9: Daxor Corp Ongoing Clinical Trials Summary
Table 10: BVA-100 - Acute Decompensated Heart Failure - Product Status
Table 11: BVA-100 - Acute Decompensated Heart Failure - Product Description
Table 12: BVA-100 - Acute Decompensated Heart Failure - Evaluation of Blood Volume Analysis- Guided Management of Decompensated Heart Failure
Table 13: BVA-100 - POTS - Product Status
Table 14: BVA-100 - POTS - Product Description
Table 15: BVA-100 Combat Casualty Care - Product Status
Table 16: BVA-100 Combat Casualty Care - Product Description
Table 17: BVA-100 Glomerular Filtration Rate - Product Status
Table 18: BVA-100 Glomerular Filtration Rate - Product Description
Table 19: Clinical Decision Support Software - Product Status
Table 20: Clinical Decision Support Software - Product Description
Table 21: Max-200 - Product Status
Table 22: Max-200 - Product Description
Table 23: Next Gen BVA-100 - Product Status
Table 24: Next Gen BVA-100 - Product Description
Table 25: Point-Of-Care Diagnostic Device - Heart Failure - Product Status
Table 26: Point-Of-Care Diagnostic Device - Heart Failure - Product Description
Table 27: Total Body Albumin Algorithm - Product Status
Table 28: Total Body Albumin Algorithm - Product Description
Table 29: Daxor Corp, Key Employees
Table 30: Daxor Corp, Key Employee Biographies
Table 31: Daxor Corp, Subsidiaries
Table 32: Glossary
List of Figures
Figure 1: Daxor Corp Pipeline Products by Equipment Type
Figure 2: Daxor Corp Pipeline Products by Development Stage
Figure 3: Daxor Corp Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings